| 1 | [SID14738243] | Active | | | Novel sEH inhibitors for the therapeutic treatment of hypertension and inflammation [AID707, Type: screening] | epoxide hydrolase 2 [Homo sapiens] [gi:27597073] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Active | | BioAssay | Novel sEH inhibitors for the therapeutic treatment of hypertension and inflammation | | AID | 707 | | BioAssay type | screening | | Target | epoxide hydrolase 2 [Homo sapiens] [gi:27597073] | | PubMed | | | Data Table |  |
|
| 2 | [SID14738243] | Active | | | Novel sEH inhibitors for the therapeutic treatment of hypertension and inflammation [AID707, Type: screening] | epoxide hydrolase 2 [Homo sapiens] [gi:27597073] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Active | | BioAssay | Novel sEH inhibitors for the therapeutic treatment of hypertension and inflammation | | AID | 707 | | BioAssay type | screening | | Target | epoxide hydrolase 2 [Homo sapiens] [gi:27597073] | | PubMed | | | Data Table |  |
|
| 3 | [SID14738243] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 4 | [SID14738243] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 5 | [SID14738243] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 6 | [SID14738243] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 7 | [SID14738243] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 8 | [SID14738243] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 9 | [SID14738243] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 10 | [SID14738243] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 11 | [SID14738243] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 12 | [SID14738243] | Inactive | Potency | 100 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | Potency | 100 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 13 | [SID14738243] | Inactive | EC50 | 300 | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | EC50 | 300 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity | | AID | 434954 | | BioAssay type | confirmatory | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 14 | [SID14738243] | Inactive | EC50 | 300 | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | EC50 | 300 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity | | AID | 434954 | | BioAssay type | confirmatory | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 15 | [SID14738243] | Inactive | EC50 | 300 | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | EC50 | 300 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity | | AID | 434954 | | BioAssay type | confirmatory | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 16 | [SID14738243] | Inactive | EC50 | 300 | Luminescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of ADP-glo Reagents [AID434947, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | EC50 | 300 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of ADP-glo Reagents | | AID | 434947 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID14738243] | Inactive | IC90 | | Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics [AID434955, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | IC90 | [uM] | | BioAssay | Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics | | AID | 434955 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID14738243] | Inactive | | | uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation [AID435003, Type: screening] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation | | AID | 435003 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID14738243] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. [AID435005, Type: screening] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. | | AID | 435005 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID14738243] | Inactive | | | uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation [AID435022, Type: screening] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation | | AID | 435022 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID14738243] | Inactive | | | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability [AID449728, Type: screening] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability | | AID | 449728 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID14738243] | Inactive | IC50 | | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media [AID449762, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media | | AID | 449762 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID14738243] | Inactive | | | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID449763, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 449763 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID14738243] | Inactive | | | uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay [AID463104, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 463104 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID14738243] | Inactive | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID14738243] | Inactive | | | HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells. [AID463075, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells. | | AID | 463075 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID14738243] | Inactive | | | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC [AID463187, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC | | AID | 463187 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID14738243] | Inactive | | | Phenotypic HTS multiplex for antifungal efflux pump inhibitors [AID485275, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Phenotypic HTS multiplex for antifungal efflux pump inhibitors | | AID | 485275 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID14738243] | Inactive | Potency | | qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion [AID485298, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion | | AID | 485298 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID14738243] | Inactive | | | Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity [AID488862, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488862 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID14738243] | Inactive | IC50 | | Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis [AID488890, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis | | AID | 488890 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID14738243] | Inactive | IC50 | | Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis [AID488966, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis | | AID | 488966 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID14738243] | Inactive | Potency | | qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling [AID493014, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling | | AID | 493014 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID14738243] | Inactive | | | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity [AID504408, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity | | AID | 504408 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID14738243] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity [AID504648, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity | | AID | 504648 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID14738243] | Inactive | Potency | | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID14738243] | Inactive | | | Small Molecules that selectively kill Giardia lamblia: qHTS [AID540267, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Small Molecules that selectively kill Giardia lamblia: qHTS | | AID | 540267 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID14738243] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID14738243] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity [AID588334, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity | | AID | 588334 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID14738243] | Inactive | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID14738243] | Inactive | | | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies [AID588358, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies | | AID | 588358 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID14738243] | Inactive | | | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity [AID588436, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity | | AID | 588436 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID14738243] | Inactive | | | uHTS identification of small molecule modulators of myocardial damage [AID588492, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule modulators of myocardial damage | | AID | 588492 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID14738243] | Inactive | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID14738243] | Inactive | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID14738243] | Inactive | IC50 | | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 [AID588727, Type: confirmatory] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 | | AID | 588727 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID14738243] | Inactive | | | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors [AID602141, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors | | AID | 602141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID14738243] | Inactive | Potency | | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID14738243] | Inactive | | | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602247, Type: screening] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602247 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID14738243] | Inactive | | | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602248, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 14738243 | | CID | 9551335 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602248 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|